Sign up to save your podcasts
Or
Share New Perspectives on Biologic Therapy in Moderate-to-Severe Ulcerative Colitis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
New Perspectives on Biologic Therapy in Moderate-to-Severe Ulcerative Colitis
CME credits: 0.25
Valid until: 13-09-2020
Claim your CME credit at https://reachmd.com/programs/cme/new-perspectives-on-biologic-therapy-in-moderate-to-severe-ulcerative-colitis/10946/
Advancements in the treatment of ulcerative colitis (UC) have given us the ability to control patient symptoms, achieve inflammation control, prolong remission, and prevent disease progression. Join Dr. David Rubin as he discusses how biologic therapies and small molecule DMARDs play a role in the UC treatment paradigm.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 13-09-2020
Claim your CME credit at https://reachmd.com/programs/cme/new-perspectives-on-biologic-therapy-in-moderate-to-severe-ulcerative-colitis/10946/
Advancements in the treatment of ulcerative colitis (UC) have given us the ability to control patient symptoms, achieve inflammation control, prolong remission, and prevent disease progression. Join Dr. David Rubin as he discusses how biologic therapies and small molecule DMARDs play a role in the UC treatment paradigm.